Modern Psychiatry And Wellness Llc - Medicare Mental Health Clinic in Hamilton, OH

Modern Psychiatry And Wellness Llc is a medicare enrolled mental health clinic (Clinic/center - Adult Mental Health) in Hamilton, Ohio. The current practice location for Modern Psychiatry And Wellness Llc is 1910 Fairgrove Ave Ste E, Hamilton, Ohio. For appointments, you can reach them via phone at (513) 795-7557. The mailing address for Modern Psychiatry And Wellness Llc is 1910 Fairgrove Ave Ste E, Hamilton, Ohio and phone number is (513) 795-7557.

Modern Psychiatry And Wellness Llc is licensed to practice in Ohio (license number ). The clinic also participates in the medicare program and its NPI number is 1225260888. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (513) 795-7557.

Contact Information

Modern Psychiatry And Wellness Llc
1910 Fairgrove Ave Ste E
Hamilton
OH 45011-1930
(513) 795-7557
(513) 297-7577

Mental Health Clinic Profile

Full NameModern Psychiatry And Wellness Llc
SpecialityClinic/Center
Location1910 Fairgrove Ave Ste E, Hamilton, Ohio
Authorized Official Name and PositionQuinton Moss (CEO)
Authorized Official Contact5138680055
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Modern Psychiatry And Wellness Llc
1910 Fairgrove Ave Ste E
Hamilton
OH 45011-1930

Ph: (513) 795-7557
Modern Psychiatry And Wellness Llc
1910 Fairgrove Ave Ste E
Hamilton
OH 45011-1930

Ph: (513) 795-7557

NPI Details:

NPI Number1225260888
Provider Enumeration Date08/17/2009
Last Update Date10/27/2020
Certification Date10/07/2020

Medicare PECOS Information:

Medicare PECOS PAC ID6608029962
Medicare Enrollment IDO20130117000157

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Medical Identifiers

Medical identifiers for Modern Psychiatry And Wellness Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1225260888NPI-NPPES
2444144MedicaidOH

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
261QM0850XClinic/center - Adult Mental Health (Ohio)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Modern Psychiatry And Wellness Llc acts as a billing entity for following providers:
Provider NameQuinton E Moss
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1306993985
PECOS PAC ID: 4880595271
Enrollment ID: I20040119000282

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Provider NameLinda Griffin Nsombi
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1649587692
PECOS PAC ID: 0547454746
Enrollment ID: I20101102000282

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Provider NameDeborah A Stevison
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1740520402
PECOS PAC ID: 9537304928
Enrollment ID: I20130408000491

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Provider NameMary Leyendecker
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1417322397
PECOS PAC ID: 3173826559
Enrollment ID: I20160119000664

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Provider NameAlicia A Johnson
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1952726556
PECOS PAC ID: 9335439579
Enrollment ID: I20160601000486

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Provider NameRyan P Glass
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1952754335
PECOS PAC ID: 3173807807
Enrollment ID: I20170224001426

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Provider NameAnn M Weber
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1073932026
PECOS PAC ID: 2567725799
Enrollment ID: I20180420001616

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Provider NameAntoinette M Thacker
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1750722286
PECOS PAC ID: 5496172504
Enrollment ID: I20200902003496

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Provider NameArrey I Eyongherok
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1205343936
PECOS PAC ID: 9931529427
Enrollment ID: I20201022001125

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Provider NameLady Christine Crockett
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1548522436
PECOS PAC ID: 9537566716
Enrollment ID: I20210930003085

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Provider NameBernice Lorene Garrison
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1912477589
PECOS PAC ID: 6507895463
Enrollment ID: I20220104002075

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Provider NameTracy L Williams
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1508318239
PECOS PAC ID: 8527438993
Enrollment ID: I20221228002997

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Provider NameErin Kutchera
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1578975785
PECOS PAC ID: 1355700634
Enrollment ID: I20230705001152

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Provider NameJoshua Reed
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1235534041
PECOS PAC ID: 0648623959
Enrollment ID: I20240201004032

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Provider NameEllen Lamm
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1811406770
PECOS PAC ID: 1658714563
Enrollment ID: I20240207004095

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Provider NameCatherine Fuller
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1023679123
PECOS PAC ID: 4183068869
Enrollment ID: I20240221002335

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Provider NameBradly Hale
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1740682863
PECOS PAC ID: 0648614255
Enrollment ID: I20240221003869

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Provider NameEric Stone
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1265086573
PECOS PAC ID: 5597100099
Enrollment ID: I20240223002268

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

Provider NameMarianna Lynn Zdinak
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1831605849
PECOS PAC ID: 0345685806
Enrollment ID: I20240224000114

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more Medical News

› Verified 4 days ago

News Archive

Age is a key factor in sex-related outcomes after heart attack, indicates study

Approximately 1.5 million heart attacks and strokes occur every year in men and women in the U.S. Sex and age play a large part in who experiences a heart attack, the methods used to treat these heart attacks, and the eventual post hospital outcomes of the people who experience heart attacks.

New report highlights effectiveness of bed rest for pregnant women

Despite lack of evidence about bed rest's effectiveness, doctors annually prescribe it for roughly 1 million pregnant women to delay preterm births. Judith Maloni, professor at the Frances Payne Bolton School of Nursing at Case Western Reserve University, said a comprehensive review of more than 70 evidence-based research articles challenges whether this is healthy for mothers or their babies.

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

Retigabine's Phase IIa clinical trial preliminary results announced

Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.

Combination of chemotherapy and selumetinib shows promise against NSCLC

A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Read more News

› Verified 4 days ago

Clinic/Center in Hamilton, OH

Hamilton Health Associates Inc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 6531 Winford Ave, Hamilton, OH 45011
Phone: 513-863-2273    
Neurology Associates Of Southern Ohio Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1010 Cereal Ave, Ste 212, Hamilton, OH 45013
Phone: 513-867-2560    Fax: 513-737-3389
Rosenzweig Psychological Services
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 935 Ridgefield Rd, Hamilton, OH 45013
Phone: 513-463-8830    
Butler Behavioral Health Services, Inc.
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 1490 University Blvd, Hamilton, OH 45011
Phone: 513-881-7189    Fax: 513-881-7188
The Fort Hamilton Hospital
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 630 Eaton Avenue, Hamilton, OH 45013
Phone: 513-585-8069    
Iris A. Pfeffer&associates
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1499 Main St, Hamilton, OH 45013
Phone: 513-737-0545    Fax: 513-737-0545
Butler Behavioral Health Services, Inc.
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1490 University Blvd, Hamilton, OH 45011
Phone: 513-881-7189    Fax: 513-881-7188

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.